Certara is a United States-based company founded in 2008, specializing in healthcare software and management consulting within the software industry. The company employs between 1,001 and 5,000 individuals and reported revenue of approximately $415 million. Certara's published documents indicate a focus on pharmacokinetics and drug development, particularly through the use of population pharmacokinetic (PopPK) analysis, which is integral in understanding dosage adjustments and therapeutic drug monitoring. Their white papers discuss the application of PopPK techniques in both late-stage and early drug development, emphasizing the importance of mathematical modeling to predict drug concentration profiles in diverse patient populations. Additionally, Certara provides practical guides related to data management and regulatory compliance, such as the development of Define XML and SDTM datasets. These resources reflect the company's commitment to supporting clinical researchers and enhancing the efficiency of drug development processes through advanced software solutions and methodological guidance.